Recombinant Anti-CA72-4 x Anti-CD3 Bispecific Antibody (Single-chain Diabody) is designed to be expressed as three chains derived from the variable domains of anti-CA72-4 and anti-CD3 parental antibodies. The middle linker is long enough to form scFv dimers between the two diabody chains. And the two Fd regions are connected by a flexible linker. This BsAb can retarget T cells to tumor cells. It is designed for the research of Gastrointestinal cancer; Ovarian cancer; Colon cancer; Gastric cancer; Breast cancer; Adenocarcinomas therapy.
https://www.creative-biolabs.com/bsab/symbolsearch-ca72-4%2520%2526%2520cd3.htm |
bio-equip.cn
Your Trusted Partner to Advance Your Biological Therapeutics Discovery and Development
Antibody Therapy
Recombinant Antibodies
Bispecific Antibodies (BsAbs)
Antibody-Drug Conjugates (ADCs)
Single Domain Antibodies (SdAbs)
De Novo Antibody Discovery
De Novo Antibody Engineering
Cellular Therapy
Chimeric Antigen Receptor (CAR) Therapy Discovery and Development
Stem Cell Therapy Discovery and Development
Gene Therapy
Oncolytic Virus Discovery and Development
mRNA Discovery and Development
Viral Vector Discovery and Development
RNAi Therapeutics Discovery and Development
Formulation & Delivery Discovery and Development
Excellence in Custom Biotechnology and Pharmaceutical Services
Phage Display & Antibody Library Services
Premade Antibody & Peptide Library Services
Preclinical Animal Model Efficacy Services
PK/PD/Toxicity Evaluation Services
Non-Human Primate (NHP) Biologicals
Membrane Protein Drug Discovery Services
中文
